Skip to content
Investing

Bannerman Energy Profile: Building Namibia's Etango Uranium Mine With a CNNC Partner

Bannerman Energy is building the Etango uranium mine in Namibia with CNNC's overseas arm. Its cash, share count, mine plan, sales terms and the dates to watch before first output in 2028.

A green road sign pointing to the Etango Mine stands beside a road roller working on the construction site in the Namibian desert.
Photo: Bannerman Energy

Bannerman Energy has turned from uranium developer into mine builder. Its Etango project in Namibia won a final investment decision in October, with first production targeted for 2028. This profile sets out what the company owns, what it has reported and what could go wrong.

What Bannerman does

Bannerman Energy is an Australian company listed on the ASX and the Namibian Stock Exchange under the code BMN, with shares also quoted on the OTCQX in the United States as BNNLF. Its single core asset is the Etango Uranium Project in Namibia, a planned open-pit mine with heap-leach processing.

Since 24 September Etango has been held through a joint venture. Bannerman owns 55% and CNNC Overseas Limited (CNOL) owns 45%. CNOL is a Hong Kong subsidiary of China National Uranium Corporation, part of the China National Nuclear Corporation group. The venture holds 95% of the project, with 5% held by the One Economy Foundation on a loan-carried basis, which leaves Bannerman with an economic interest of 52.25%.

CNOL paid US$320.4m in total: US$294.5m into the joint venture and US$25.9m to Bannerman as reimbursement for Etango spending since July 2025. From completion, Bannerman accounts for its share of the venture as an equity investment, so the venture's cash no longer appears in Bannerman's consolidated cash balance.

Bannerman Energy: share price, chart and news

Aerial view of the Etango site in the Namib desert, with the excavated primary crusher pit and the cleared road and conveyor line leading away from it.
Aerial view of the Etango site in the Namib desert, with the excavated primary crusher pit and the cleared road and conveyor line leading away from it. Photo: Bannerman Energy

The Etango mine plan

The approved design is Etango-8, from a definitive feasibility study published in December 2022. On a 100% basis, Bannerman's November investor presentation lists the following:

ItemEtango-8
Mineral Resource (100ppm cut-off)206.8m lb U3O8 at 225ppm
Ore Reserve59.9m lb U3O8 at 240ppm
Throughput8m tonnes a year
Initial mine life15 years
Average output3.5m lb U3O8 a year
All-in sustaining costUS$39.1/lb
Pre-production capitalUS$353m (±10%)
Post-tax NPV at 8%, US$95/lbUS$614m
Post-tax IRR26.7%

These are study estimates, not operating results. An expansion case, Etango-16, would double throughput to 16m tonnes a year and lift output to 6.7m lb a year after expansion. It is not part of the approved build.

The project has moved in steps. Etango received its mining licence in December 2023 and holds its environmental approvals, early works began in January 2024 and a control budget estimate followed in June 2024. The CNOL agreements were signed in February 2026 and completed in September, and the joint venture took its final investment decision on 23 October. Danie van Aswegen, previously chief operating officer in Namibia, now runs the local operating company. At board level, non-executive director Danny Goeman resigned on 15 October, before the annual meeting on 5 November.

Latest reported numbers

In its report for the three months to 30 September, Bannerman reported about A$175m of cash outside the joint venture. The venture held about US$295m, excluding cash in its Namibian subsidiaries. The company has no debt.

Balance sheet and capital

  • A$174.6m Bannerman cash at 30 September
  • US$295m Etango JV cash at 30 September
  • 239.1m shares on issue at 10 November

The quarter included a fully underwritten A$124m institutional placement of 31m shares at A$4.00 each, issued on 16 September. A share purchase plan at the same price closed on 2 October and raised a further A$0.44m. Shares on issue stood at 239,010,167 at the report date, alongside about 2.55m unlisted options; the November presentation gives 239.1m shares. The November presentation put the share price at A$3.70 at the 10 November close, below the placement price, for a market value of A$885m.

Bannerman also holds units in the Sprott Physical Uranium Trust worth about A$11.7m and 101.3m shares in Namibia Critical Metals worth about A$17.4m, both valued at 30 September.

Construction progress and sales

About US$64m had been spent on early works by the end of September, and about 523 contractor staff were on site. Bulk earthworks were about 99% complete, with the last phase, covering process ponds and plant terraces, due to finish in December 2026. Dry plant civil and mechanical design was about 98% complete and wet plant structural engineering about 33%. The first phase of the permanent water pipeline was about 90% complete under an agreement with the state water utility NamWater, and early procurement for the power supply under an agreement with NamPower is planned for the fourth quarter.

CNOL will buy 60% of Etango's output at market prices, set by spot and term uranium indices at delivery, with no floor and no ceiling. Bannerman plans to sell the other 40% itself to a spread of buyers.

The site recorded its first lost-time injury in more than 16 years on 2 September, when a contractor suffered a hairline foot fracture.

Main risks and what to watch

What could go wrong

  • Cost and schedule. The US$353m estimate carries a ±10% range; overruns beyond JV cash would need new partner funding.
  • Uranium price. Sales are linked to market prices with no floor, so lower prices would cut revenue directly.
  • Single asset, single country. Bannerman's value rests on one mine in Namibia, with power, water and acid supply still being built.
  • Shared control. Key decisions are taken with a state-owned partner that also buys most of the output.
  • No income before 2028. The company relies on cash in hand until production starts.

The uranium spot price ended September at US$89.75/lb and the long-term price at US$97.00/lb, according to TradeTech and UxC figures cited by Bannerman. The study economics above assume US$95/lb.

WhenWhat to watch
Coming monthsMove from early works to full-scale construction
Q4 2026Early procurement for the NamPower supply
December 2026Completion of the final bulk earthworks phase
By end of January 2027December-quarter activities report, due under ASX rules
2028Targeted commissioning and first production

Investors will also look for sales contracts covering the 40% of output that Bannerman markets itself.

Sources

Related stories

Business

Bannerman Energy Approves the Etango Uranium Mine Build, Targeting First Output in 2028

Bannerman Energy and CNNC's overseas arm have taken a final investment decision on Etango in Namibia: about US$353m of capital, 3.5m lb of uranium a year and first output targeted…

Investing

Boss Energy Profile: Honeymoon, Alta Mesa and a Year of Transition for the Uranium Producer

Boss Energy mines uranium at Honeymoon in South Australia and owns 30% of Alta Mesa in Texas. It has no debt and a large stockpile, but output falls this year as it changes mining…

Investing

Reconnaissance Energy Africa: An Explorer Waiting on Its First Measured Flow in Namibia

ReconAfrica explores the Kavango Basin in Namibia and holds an offshore block in Gabon. It has no revenue and funds itself with share sales. Its assets, cash, risks and the dates…

Investing

Denison Mines Investor Profile: Wheeler River, the Phoenix Build and the Road to 2028

Denison Mines is building Phoenix, a high-grade in-situ uranium mine in Saskatchewan, with first output targeted for late 2028. Its assets, latest numbers, funding, risks and the…

Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…